KKR builds stake in Henry Schein, reaches deal to add board seats
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...
Henry Schein announces KKR investment, prelim. Q4 sales (update)
Henry Schein (HSIC) stock in focus as KKR (KKR) builds stake and the company posts its preliminary Q4 2024 financials. Read ...
Hold Rating Maintained for Henry Schein Amid Strategic Investment by KKR and Soft Operational Performance
Mizuho Securities analyst Steven Valiquette has maintained their neutral stance on HSIC stock, giving a Hold rating on January 23.Invest with ...
KKR builds stake in Henry Schein, agrees deal for board seats, WSJ reports
Private equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of medical products to ...
MassDevice1d
Henry Schein gets a major private equity investment
Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...
Henry Schein price target raised to $90 from $82 at Barrington
Barrington analyst Michael Petusky raised the firm’s price target on Henry Schein (HSIC) to $90 from $82 and keeps an Outperform rating on the ...